Elicio Therapeutics (ELTX) Other Non-Current Assets (2021 - 2026)

Elicio Therapeutics (ELTX) has reported Other Non-Current Assets for 6 consecutive years, with $825000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets rose 17.86% year-over-year to $825000.0; the trailing twelve-month figure through Jun 2026 stood at $825000.0 (up 17.86% YoY), and the FY2025 full-year result was $800000.0, up 14.94% from the prior year.
• Other Non-Current Assets eased to $825000.0 in Q2 2026 per ELTX's latest filing, from $1.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.8 million in Q2 2023 and bottomed at $75000.0 in Q3 2022.
• Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $812500.0 in 2025.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 3677.33% in 2023, then tumbled 75.54% in 2024.
• Over 5 years, Other Non-Current Assets stood at $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then slumped by 75.43% to $696000.0 in 2024, then advanced by 14.94% to $800000.0 in 2025, then grew by 3.12% to $825000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $825000.0, $1.0 million, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.